Companies: 10,795·Total market cap: $144.5T
Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc.

KLTONASDAQHealthcare
$0.38
$-0.03(-7.10%)
Market Cap$20079881
P/E Ratio
52W High$3.91
52W Low$0.114

Klotho Neurosciences, Inc. (KLTO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

KLTO · net income · updated Jun 9, 2026

Core profitability metrics

Net income was −$6.2M for FY2024 (fiscal year ending 2024-12-31), down 769.4% year-over-year. Net profit margin was —.

FY2024 Net Income−$6.2M▼ -769.4% YoY
Trailing 12M (TTM)−$11.3Mtrailing 4 quarters sum
Net Profit Margin
YoY Change-769.4%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · KLTO net income history · KLTO profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2024Loss−$6.2M▼ 769.4%
FY2023Loss−$707,458▼ 18.2%
FY2022Loss−$598,593▲ +46.0%
FY2021Loss−$1.1M

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Klotho Neurosciences, Inc.
Klotho Neurosciences, Inc.YOU
KLTO
−$6.2M-769.4%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Klotho Neurosciences, Inc. (KLTO) reported net income of −$6.2M for FY2024 (fiscal year ending 2024-12-31), down 769.4% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Klotho Neurosciences, Inc. has not yet achieved annual profitability based on available data (4 fiscal years). The company has reported net losses across all available periods.

Klotho Neurosciences, Inc.'s net profit margin was — for FY2024, based on the latest annual results.

Investors sometimes search for "Klotho Neurosciences, Inc. net worth" — the company's market capitalization is a separate figure from KLTO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

KLTO net income · 4 questions

Klotho Neurosciences, Inc. is not currently profitable on an annual basis. The company reported a net loss of $6.2M for FY2024.

is KLTO profitabledoes KLTO make a profitKLTO profitabilityKLTO profitable company

Source: FMP /income-statement · GAAP · Klotho Neurosciences, Inc. · Klotho Neurosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026